These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2679841)

  • 1. Acute and cumulative effects of carboplatin on renal function.
    Sleijfer DT; Smit EF; Meijer S; Mulder NH; Postmus PE
    Br J Cancer; 1989 Jul; 60(1):116-20. PubMed ID: 2679841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of nephrotoxicity of new oral platinum drug JM216 in lung cancer patients.
    Fokkema E; de Vries EG; Meijer S; Groen HJ
    Cancer Chemother Pharmacol; 2000; 45(1):89-92. PubMed ID: 10647508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations on the acute and chronic nephrotoxicity of the new platinum analogue carboplatin.
    Metz-Kurschel U; Kurschel E; Niederle N; Aulbert E
    J Cancer Res Clin Oncol; 1990; 116(2):203-6. PubMed ID: 2182639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxicity of 1,1-diaminomethylcyclohexane sulphato platinum II (spiroplatin; TNO-6).
    Offerman JJ; Meijer S; Mulder NH; Sleijfer DT; Bijster P; Hellendoorn HB; Donker AJ; van der Hem GK
    Eur J Cancer Clin Oncol; 1985 Apr; 21(4):447-51. PubMed ID: 3891361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal dysfunction following high-dose carboplatin treatment.
    Mulder PO; Sleijfer DT; de Vries EG; Uges DR; Mulder NH
    J Cancer Res Clin Oncol; 1988; 114(2):212-4. PubMed ID: 3280573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboplatin and renal function.
    Smit EF; Sleijfer DT; Meijer S; Mulder NH; Postmus PE
    Ann Intern Med; 1989 Jun; 110(12):1034. PubMed ID: 2658713
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of oxoplatinum and CBDCA on renal functions in rats.
    Láznícková A; Semecký V; Láznícek M; Zubr V; Koksál J; Kvĕtina J
    Neoplasma; 1989; 36(2):161-9. PubMed ID: 2654665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma.
    Meijer S; Sleijfer DT; Mulder NH; Sluiter WJ; Marrink J; Koops HS; Brouwers TM; Oldhoff J; van der Hem GK; Mandema E
    Cancer; 1983 Jun; 51(11):2035-40. PubMed ID: 6340821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of gemcitabine on renal function in patients with non-small cell lung cancer.
    Gietema JA; Groen HJ; Meijer S; Smit EF
    Eur J Cancer; 1998 Jan; 34(1):199-202. PubMed ID: 9624259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose individualization can minimize nephrotoxicity due to carboplatin therapy in patients with ovarian cancer.
    Donadio C; Lucchesi A; Ardini M; Cosio S; Fanucchi A; Gadducci A
    Ther Drug Monit; 2009 Feb; 31(1):63-9. PubMed ID: 19077927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men.
    Muskiet MH; Tonneijck L; Smits MM; Kramer MH; Diamant M; Joles JA; van Raalte DH
    Diabetes Obes Metab; 2016 Feb; 18(2):178-85. PubMed ID: 26636423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of combination chemotherapy with cis-diamminedichloroplatinum on renal function: long-term effects.
    Meijer S; Mulder NH; Sleijfer DT; Donker AJ; Sluiter WJ; de Jong PE; Schraffordt Koops H; van der Hem GK
    Oncology; 1983; 40(3):170-3. PubMed ID: 6189040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function after ifosfamide, carboplatin and etoposide (ICE) chemotherapy, nephrectomy and radiotherapy in children with Wilms tumour.
    Daw NC; Gregornik D; Rodman J; Marina N; Wu J; Kun LE; Jenkins JJ; McPherson V; Wilimas J; Jones DP
    Eur J Cancer; 2009 Jan; 45(1):99-106. PubMed ID: 18996004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative nephrotoxicity of carboplatin and cisplatin in euvolemic and dehydrated rats.
    Martinez F; Deray G; Dubois M; Beaufils H; Jacquiaud C; Bourbouze R; Benhmida M; Jaudon MC; Jacobs C
    Anticancer Drugs; 1993 Feb; 4(1):85-90. PubMed ID: 8457719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-related nephrotoxicity of carboplatin in children.
    English MW; Skinner R; Pearson AD; Price L; Wyllie R; Craft AW
    Br J Cancer; 1999 Sep; 81(2):336-41. PubMed ID: 10496362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral cyclosporin on renal function in Crohn's disease.
    Lobo AJ; Juby LD; Smith AH; Foster PN; Rothwell J; Pentith J; Poole TW; Axon AT
    Dig Dis Sci; 1993 Sep; 38(9):1624-30. PubMed ID: 8359074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative intravenous infusion of alprostadil (PGE1) does not improve renal function in hepatic transplant recipients.
    Manasia AR; Leibowitz AB; Miller CM; Silverstein JH; Schwartz M; Delgiudice R; Vallabhajosula S; Oropello JM; Benjamin E
    J Am Coll Surg; 1996 Apr; 182(4):347-52. PubMed ID: 8605558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary protein and enzyme excretion in patients receiving chemotherapy with the cis-platinum analogs carboplatin (CBDCA, JM8) and iproplatin (CHIP, JM9).
    Skillen AW; Buamah PK; Cantwell BM; Cornell C; Hodson AW; Harris AL
    Cancer Chemother Pharmacol; 1988; 22(3):228-34. PubMed ID: 3044631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
    Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.